KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding: 2011-2025

Historic Shares Outstanding for Sarepta Therapeutics (SRPT) over the last 8 years, with Sep 2025 value amounting to $105.4 million.

  • Sarepta Therapeutics' Shares Outstanding rose 10.39% to $105.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.4 million, marking a year-over-year increase of 10.39%. This contributed to the annual value of $96.9 million for FY2024, which is 3.38% up from last year.
  • Sarepta Therapeutics' Shares Outstanding amounted to $105.4 million in Q3 2025, which was up 7.18% from $98.4 million recorded in Q2 2025.
  • Sarepta Therapeutics' Shares Outstanding's 5-year high stood at $105.4 million during Q3 2025, with a 5-year trough of $79,748 in Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding was $95.3 million (2024), whereas its average is $70.7 million.
  • Per our database at Business Quant, Sarepta Therapeutics' Shares Outstanding slumped by 99.90% in 2021 and then skyrocketed by 109,663.75% in 2022.
  • Sarepta Therapeutics' Shares Outstanding (Quarterly) stood at $87,127 in 2021, then grew by 0.94% to $87,950 in 2022, then soared by 106,474.19% to $93.7 million in 2023, then rose by 3.38% to $96.9 million in 2024, then climbed by 10.39% to $105.4 million in 2025.
  • Its Shares Outstanding stands at $105.4 million for Q3 2025, versus $98.4 million for Q2 2025 and $98.3 million for Q1 2025.